3-喹啉乙腈 | 21863-57-0

• 物质功能分类: 化学试剂 - 有机试剂 - 氰化物/腈
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 3-喹啉乙腈
• 英文名称: 3-quinolineacetonitrile
• 英文别名: 3-cyanomethylquinoline；3-Chinolylacetonitril；3-Cyanomethylchinolin；quinolin-3-yl-acetonitrile；2-(Quinolin-3-yl)acetonitrile；2-quinolin-3-ylacetonitrile
• CAS: 21863-57-0
• 化学式: C₁₁H₈N₂
• mdl: MFCD03412550
• 分子量: 168.198
• InChiKey: AMNPNQPJCREQBE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  36.7
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933499090

反应信息

• 作为反应物：
  描述：

  3-喹啉乙腈 在 palladium on activated charcoal 氢气 、 三乙酰氧基硼氢化钠 、 溶剂黄146 、 三氟乙酸 作用下， 以 甲醇 、 1,2-二氯乙烷 为溶剂， 反应 3.0h， 生成 3-[4-[[[2-(3-quinolinyl)ethyl]amino]methyl]phenyl]-(2E)-2-propenoic acid methyl ester
  参考文献：
  名称：

  N-Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity:  Discovery of (2E)-N-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)

  摘要：

  A series of N-hydroxy-3-phenyl-2-propenamides were prepared as novel inhibitors of human histone deacetylase (HDAC). These compounds were potent enzyme inhibitors, having IC(50)s < 400 nM in a partially purified enzyme assay. However, potency in cell growth inhibition assays ranged over 2 orders of magnitude in two human carcinoma cell lines. Selected compounds having cellular IC50 < 750 nM were tested for maximum tolerated dose (MTD) and for efficacy in the HCT116 human colon tumor xenograft assay. Four compounds having an MTD 100 mg/kg were selected for dose-response studies in the HCT116 xenograft model. One compound, 9 (NVP-LAQ824), had significant dose-related activity in the HCT116 colon and A549 lung tumor models, high MTD, and low gross toxicity. On the basis, in part, of these properties, 9 has entered human clinical trials in 2002.

  DOI：

  10.1021/jm030235w
• 作为产物：
  描述：

  喹啉-3-基甲醇 在 氯化亚砜 、 potassium iodide 作用下， 以 乙醇 、 水 、 苯 为溶剂， 反应 5.0h， 生成 3-喹啉乙腈
  参考文献：
  名称：

  Two New Quinazoline-Quinoline Alkaloids from Peganum nigellastrum

  摘要：

  DOI：

  10.3987/com-99-8595

文献信息

• Radical cyanomethylation <i>via</i> vinyl azide cascade-fragmentation
  作者：James R. Donald、Sophie L. Berrell

  DOI：10.1039/c9sc01370a

  日期：——

  Herein, a novel methodology for radical cyanomethylation is described. The process is initiated by radical addition to the vinyl azide reagent 3-azido-2-methylbut-3-en-2-ol which triggers a cascade-fragmentation mechanism driven by the loss of dinitrogen and the stabilised 2-hydroxypropyl radical, ultimately effecting cyanomethylation. Cyanomethyl groups can be efficiently introduced into a range of

  在此，描述了用于自由基氰基甲基化的新方法。该过程是通过将自由基添加到叠氮化乙烯试剂3-叠氮基-2-甲基丁-3-烯-2-醇中而引发的，该自由基触发了级联碎片化机理，该机理由二氮和稳定的2-羟丙基自由基的损失驱动，最终实现了氰基甲基化。通过捕获在光氧化还原催化和非催化条件下由各种官能团产生的α-羰基，杂苄基，烷基，磺酰基和芳基，可以将氰甲基有效地引入一系列底物中。这种方法的价值可以通过药物的后期氰甲基化来例证。
• QUINOLINYL AND BENZOTHIAZOLYL MODULATORS
  申请人：——

  公开号：US20020169185A1

  公开（公告）日：2002-11-14

  Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPAR&ggr;. In particular, the compounds of the invention modulate the function of PPAR&ggr;. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.

  本发明提供有用于治疗或预防由PPAR&ggr;介导的疾病或疾病的化合物、组合物和方法。特别地，本发明的化合物调节PPAR&ggr;的功能。该方法特别适用于治疗和/或预防糖尿病、肥胖症、高胆固醇血症、类风湿性关节炎和动脉粥样硬化。
• Quinolinyl and benzothiazolyl modulators
  申请人：Tularik Inc.

  公开号：US20030171399A1

  公开（公告）日：2003-09-11

  Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPAR&ggr;. In particular, the compounds of the invention modulate the function of PPAR&ggr;. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.

  本发明提供了一些化合物、组合物和方法，这些化合物、组合物和方法对于治疗或预防由PPAR&ggr;介导的疾病或疾患非常有用。特别地，本发明的化合物调节PPAR&ggr;的功能。这些方法特别适用于治疗和/或预防糖尿病、肥胖症、高胆固醇血症、类风湿性关节炎和动脉粥样硬化。
• POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS
  申请人：Luo Steven

  公开号：US20090099325A1

  公开（公告）日：2009-04-16

  A method for preparing a functionalized polymer, the method comprising the steps of preparing a reactive polymer and reacting the reactive polymer with a heterocyclic nitrile compound.

  一种制备功能化聚合物的方法，包括以下步骤：制备一种反应性聚合物，并将该反应性聚合物与杂环腈化合物反应。
• Photoinduced Nickel-Catalyzed Demethylative Cyanation and Decarboxylative Cyanomethylation of Aryl Halides
  作者：Shao-Chi Lee、Chen Zhu、Kun Huang、Jeremy A. Bau、Jiaqi Jia、Huifeng Yue、Magnus Rueping

  DOI：10.1021/acscatal.3c04745

  日期：2023.12.15

  nickel-catalyzed demethylative cyanation and decarboxylative cyanomethylation of aryl halides are described here. Commercially available bromoacetonitrile was found to act as an efficient cyanating reagent for the photoinduced cyanation reaction in the absence of a photocatalyst. Moreover, photoredox and nickel dual-catalyzed decarboxylative cyanomethylation of aryl halides has also been realized using

  本文描述了芳基卤化物的光诱导镍催化脱甲基氰化和脱羧氰甲基化。人们发现市售的溴乙腈在没有光催化剂的情况下可作为光诱导氰化反应的有效氰化试剂。此外，利用氰乙酸铯在温和条件下实现了芳基卤化物的光氧化还原和镍双催化脱羧氰甲基化。以良好至高效的方式制备了一系列带有不同官能团的芳基和苄基腈。